Remission of severe cold agglutinin disease after rituximab therapy

Leukemia

Volumn 15, Issue 1, 2001, Pages 187-188

  Layios, N ^a   Van Den Neste, E ^a   Jost, E ^a   Deneys, V ^a   Scheiff, J M ^a   Ferrant, A ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CD20 ANTIGEN; CHLORAMBUCIL; COLD AGGLUTININ; COMPLEMENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DANAZOL; DEXAMETHASONE; HAPTOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; RITUXIMAB; VINCRISTINE;

ACROCYANOSIS; AGED; ANTIGEN EXPRESSION; CASE REPORT; DISEASE SEVERITY; DYSERYTHROPOIESIS; DYSPNEA; FEMALE; GENE REARRANGEMENT; HEMATOCRIT; HEMOLYSIS; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MEGAKARYOCYTE; NONHODGKIN LYMPHOMA; PANCYTOPENIA; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; RETICULOCYTE COUNT;

EID: 0035141159     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401976     Document Type: Letter

References (8)

1. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
2. Rituximab therapy in Waldenstrom's macroglobulinemia: Preliminary evidence of clinical activity
3. Alpha-interferon for severe cold agglutinin disease
4. Rituxan in the treatment of cold agglutinin disease
5. Rituximab for the treatment of type II mixed cryoglobulinemia
6. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab
7. Upregulation of CD20 expression in chronic lymphocytic leukemia (CLL) cells by in vitro exposure to cytokines
8. The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29